A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles
- 1 February 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (2) , 437-444
- https://doi.org/10.1021/jm00122a025
Abstract
Antagonism of mercaptopropionic acid (MPA) induced convulsions, reflecting a GABAergic mechanism, was observed in a series of 1-ary-3-(aminoalkylidene)oxindoles. Optimal MPA antagonism was associated with 3-halo, 3-alkyl, and/or 4-alkoxy substituents in the pendant aryl ring and with (dimethylamino)methylene, 1-(dimethylamino)-ethylidene and N-methyl-2-pyrrolidinylidene side chains. The precise mechanism of action of these agents is unclear at this time; however, they are not GABA mimics and they do not affect GABA levels. Like other GABAergic agents, these compounds are potent enhancers of benzodiazepine binding and they antagonize cyclic GMP elevations induced by isoniazid. Compounds from this series may therefore have potential therapeutic utility as anticonvulsants or anxiolytics.This publication has 11 references indexed in Scilit:
- Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with gabaergic agentsLife Sciences, 1984
- Contrasting effects of ethyl β-carboline-3-carboxylate (βCCE) and diazepam on cerebellar cyclic GMP content and antagonism of both effects by Ro 15-1788, a specific benzodiazepine receptor blockerEuropean Journal of Pharmacology, 1983
- The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1Pharmacology Biochemistry and Behavior, 1983
- Enhancement of benzodiazepine binding by progabide (SL 76002) and SL 75102Drug Development Research, 1983
- Enhancement of benzodiazepine and GABA binding by the novel anxiolytic, tracazolateEuropean Journal of Pharmacology, 1982
- GABA agonistsMolecular and Cellular Biochemistry, 1981
- Inhibitors of GABA metabolismBiochemical Pharmacology, 1979
- Valproic acid (Depakene). A new anticonvulsant agentJAMA, 1978
- Measuring changes in cerebral glutamate and gaba metabolism prior to convulsions induced by 3-mercaptopropionateBiochemical Pharmacology, 1978
- Synthesis of New 3-(Pyridylmethylene)-, 3-(Pyridylmethyl)-, 3-(Piperidylmethyl)-, and 3-(β-Alkylaminoethyl)-2-indolinones. The Reduction of Isoindogenides, Nitro Compounds, and Pyridines in a Series of 2-IndolinonesJournal of Medicinal Chemistry, 1965